Venclexta 100 MG tablet UU 120S
Ended Awarded Last action
- Contract number
- SPE2DR26F0M16
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,366
Award facts
- Contract value 100% obligated
- $10,366.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $10,366.08 delivery order to AmerisourceBergen Drug Corp for the supply of Venclexta 100 mg tablets (120-count units) on January 12, 2026, with completion expected by February 3, 2026. This competitively awarded, firm fixed-price contract is not set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999.99 million through December 31, 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated significant capability in fulfilling federal medical procurement requirements across multiple therapeutic domains. The company's contract portfolio with the DLA includes extensive delivery of brand-name and generic medications, vaccines, and specialized healthcare commodities to military treatment facilities and other federal medical institutions. This delivery order for Venclexta, a oncology medication, exemplifies the contractor's role as a critical vendor in the federal pharmaceutical supply chain, supporting the Defense Health Agency and other government healthcare systems through flexible and comprehensive contract vehicles.
Quick answers
Who was awarded contract SPE2DR26F0M16?
SPE2DR26F0M16 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26F0M16 worth?
The government has obligated $10,366 on SPE2DR26F0M16.
Is contract SPE2DR26F0M16 an order under another contract?
Yes. SPE2DR26F0M16 is a delivery order under SPE2DR25D2207, an indefinite delivery contract.
Was contract SPE2DR26F0M16 competed?
The extent of competition for SPE2DR26F0M16 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award